Thomas Gurley
Infectious Disease · Atlanta, GANPI 1326224635
Payments from drug & device makers
Across 482 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- Viiv Healthcare Company$1K
- Merz North America, Inc.$639
- Johnson & Johnson$560
- Merck$467
- Novo Nordisk$444
- plus $4K from 41 others
What the payments were for
- Speaking & faculty fees$1652%
- Food & beverage$8,40297%
- Education$1151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,682 in reported general payments places this provider in the 70th percentile of 260 infectious disease providers in Georgia.
Other infectious disease in Atlanta
- Mark MulliganAtlanta$4.6M
- Nadine RouphaelAtlanta$2.4M
- Leila HojatAtlanta$2.2M
- Kimberly WorkowskiAtlanta$2M
- Zandraetta Tims-CookAtlanta$878K
- Scott FridkinAtlanta$774K
- Colleen KelleyAtlanta$738K
- Leandro MenaAtlanta$733K
- Srilatha EdupugantiAtlanta$726K
- Larry AndersonAtlanta$694K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.